Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Quarterly Revenue and Segment Performance
TECH logo

Bio-Techne Operating Income Surges 95% Despite 2% Revenue Dip

TECH10-QFiling Date: 5/6/2026
Bio-Techne Corporation
Description

What this story covers

Bio-Techne demonstrated strong fiscal discipline in Q3 2026, nearly doubling operating income to $75.5 million through aggressive cost-cutting. Despite a 2% revenue decline and divestiture impacts, the company significantly reduced debt to prepare for a $1 billion acquisition commitment.

Story snapshot

CompanyBio-Techne Corporation
TickerTECH
VariantStandard detailed
Duration13:45
Filing type10-Q
PeriodQ4 2026
IndustryHealthcare & Pharmaceuticals
Accession0001104659-26-056302
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-QView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in